Michael L. Corman

1.6k citations

13 papers · 1.3k indexed · h-index 11

Molecular Biology top 10%
Behavioral Neuroscience top 1%
Pharmacology top 5%
Cellular and Molecular Neuroscience top 10%
Organic Chemistry top 10%

Co-authors: Rodney C. Schnur Anne W. Schmidt Randall J. Gallaschun F. David Tingley Robert S. Mansbach David W. Schulz P A Seymour Jonathan L. Doty
Topics: Receptor Mechanisms and Signaling (4 papers)Cholinesterase and Neurodegenerative Diseases (4 papers)Phosphodiesterase function and regulation (4 papers)
Cited by: Behavioral Neuroscience Biological Psychiatry Pharmacology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Journal of Medicinal Chemistry
Partner nations: United States

In The Last Decade

Michael L. Corman

13 papers receiving 1.3k citations

Peers

Countries citing papers authored by Michael L. Corman

Since Specialization

Citations

This map shows the geographic impact of Michael L. Corman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Corman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Corman more than expected).

Fields of papers citing papers by Michael L. Corman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Corman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Corman. The network helps show where Michael L. Corman may publish in the future.

Co-authorship network of co-authors of Michael L. Corman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Corman. A scholar is included among the top collaborators of Michael L. Corman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Corman. Michael L. Corman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity 2019 ·Journal of Biological Chemistry ·Pathricia V. Tilstam,Georgios Pantouris,Michael L. Corman,Monica Andreoli,Keyvan Mahboubi,Gary L. Davis,Xin Du,Lin Leng,Elias Lolis,Richard Bucala	29
2	Design and Discovery of 6-[(3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders 2012 ·Journal of Medicinal Chemistry ·Patrick R. Verhoest,Kari R. Fonseca,Xinjun Hou,(unknown),Michael L. Corman,Christopher J. Helal,Michelle M. Claffey,Jamison B. Tuttle,Karen J. Coffman,(unknown),Frederick Nelson,Robin J. Kleiman,Frank S. Menniti,Christopher J. Schmidt,Michelle Vanase‐Frawley,Spiros Liras	53
3	Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1 H -pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1). 2009 ·Journal of Medicinal Chemistry ·Patrick R. Verhoest,Douglas S. Chapin,Michael L. Corman,Kari R. Fonseca,John F. Harms,Xinjun Hou,Eric S. Marr,Frank S. Menniti,Frederick Nelson,Rebecca E. O’Connor,Jayvardhan Pandit,(unknown),Anne W. Schmidt,Christopher J. Schmidt,(unknown),Spiros Liras	172
4	Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy 2009 ·Journal of Medicinal Chemistry ·Patrick R. Verhoest,(unknown),Michael L. Corman,(unknown),Christopher J. Helal,Xinjun Hou,Robin J. Kleiman,Shenping Liu,Eric S. Marr,Frank S. Menniti,Christopher Schmidt,Michelle Vanase‐Frawley,Anne W. Schmidt,Robert D. Williams,Frederick Nelson,Kari R. Fonseca,Spiros Liras	45
5	Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia 2008 ·Journal of Pharmacology and Experimental Therapeutics ·C J Schmidt,Douglas S. Chapin,(unknown),Michael L. Corman,Mihály Hajós,John F. Harms,William E. Hoffman,Lorraine A. Lebel,Sheryl A. McCarthy,(unknown),(unknown),Mark J. Majchrzak,Andres D. Ramirez,Karl T. Schmidt,P A Seymour,Judith A. Siuciak,F. David Tingley,Robert D. Williams,Patrick R. Verhoest,Frank S. Menniti	238
6	2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists 2008 ·Journal of Medicinal Chemistry ·Yuhpyng L. Chen,R. Scott Obach,John P. Braselton,Michael L. Corman,(unknown),(unknown),Randall J. Gallaschun,Robert S. Mansbach,Anne W. Schmidt,Jeffrey Sprouse,F. David Tingley,(unknown),David W. Schulz	52
7	Thiazole-diamides as potent γ-secretase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yuhpyng L. Chen,(unknown),Michael L. Corman,(unknown),(unknown),Dane Liston,(unknown),Christine Oborski,Barbara G. Sahagan	10
8	Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally Active Corticotropin-Releasing Factor₁ Receptor Antagonist 1997 ·Journal of Medicinal Chemistry ·Yuhpyng L. Chen,Robert S. Mansbach,Steven M. Winter,(unknown),Judith M. Collins,Michael L. Corman,A. DUNAISKIS,W. Stephen Faraci,Randall J. Gallaschun,Anne W. Schmidt,David W. Schulz	93
9	CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. 1996 ·Proceedings of the National Academy of Sciences ·David W. Schulz,Robert S. Mansbach,Jeffrey Sprouse,John P. Braselton,J.L. Collins,Michael L. Corman,A. DUNAISKIS,(unknown),Anne W. Schmidt,Thomas Seeger,P A Seymour,F. David Tingley,(unknown),(unknown),James Heym	308
10	erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships 1995 ·Journal of Medicinal Chemistry ·Rodney C. Schnur,Michael L. Corman,Randall J. Gallaschun,Beth Cooper,Michael F. Dee,Jonathan L. Doty,(unknown),(unknown),Elsa G. Barbacci	110
11	Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives 1995 ·Journal of Medicinal Chemistry ·Rodney C. Schnur,Michael L. Corman,Randall J. Gallaschun,Beth Cooper,Michael F. Dee,Jonathan L. Doty,(unknown),James D. Moyer,(unknown)	162
12	Tandem [3,3]-Sigmatropic Rearrangements in an Ansamycin: Stereospecific Conversion of an (S)-Allylic Alcohol to an (S)-Allylic Amine Derivative 1994 ·The Journal of Organic Chemistry ·Rodney C. Schnur,Michael L. Corman	48
13	Preparation of 17‐amino‐22‐(4′‐azido‐3′‐¹²⁵iodophenacyl)‐17‐demethoxygeldanamycin (1): An ansamycin for photoaffinity labeling 1994 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Rodney C. Schnur,Michael L. Corman	8

About Michael L. Corman

Michael L. Corman is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Pharmacology, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Phosphodiesterase function and regulation (4 papers). The work is most often cited by research in Behavioral Neuroscience (385 citations), Biological Psychiatry (148 citations) and Pharmacology (336 citations). Michael L. Corman has collaborated with scholars based in United States. Frequent co-authors include Rodney C. Schnur, Anne W. Schmidt, Randall J. Gallaschun, F. David Tingley, Robert S. Mansbach, David W. Schulz, P A Seymour, Jonathan L. Doty, Michael F. Dee and Beth Cooper. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact